Citius Oncology CTOR
NASDAQ CTOR
$0.70 +0.03 (+4.37%)
At close: Oct 21, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Times Interest Earned (2025 - 2026)

Updated

Citius Oncology's (CTOR) Times Interest Earned was -37.62 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -30.76 a year earlier.

Analysis

Citius Oncology (CTOR) Times Interest Earned (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Citius Oncology's Times Interest Earned came in at -128.56; for FY2025 (ended Sep 30, 2025), it was -107.89.

  • Five-year quarterly Times Interest Earned spans a low of -866.26 in fiscal Q2 2026 and a high of -30.76 in fiscal Q3 2025.
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -866.26 (Q2 2026), -114.58 (Q1 2026) and -82.26 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Citius Oncology 72.00 Mn 41.58 Mn 1.00 Mn -37.62
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.62
Mar 31, 2026 -866.26
Dec 31, 2025 -114.58
Sep 30, 2025 -82.26
Jun 30, 2025 -30.76
API Access

Citius Oncology Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=CTOR&period=max&api_key=YOUR_API_KEY